The Effect of AI-Assisted Nursing Process Training on Nursing Process Competence, Perception and Attitudes Towards Artificial Intelligence in Nurses: A Randomized Controlled Study
Hemşirelerde Yapay Zeka Destekli Hemşirelik Süreci Eğitiminin Hemşirelik Süreci Yetkinliğine, Yapay Zeka Algı ve Tutumuna Etkisi: Randomize Kontrollü Bir Çalışma
This study aims to determine how applied artificial intelligence (AI) training affects nurses' ability to manage the nursing process and their perceptions and attitudes toward AI technology
- The nursing process is a scientific, six-stage approach used by nurses to identify patient needs and provide holistic care
The research is a randomized controlled trial involving 78 nurses at Yalova Education and Research Hospital
. Participants will be split into two groups: Both groups will receive standard theoretical training on the nursing process
. The intervention group will receive additional specialized training on using AI tools (such as ChatGPT and Deepseek) to help create nursing care plans through practical case studies
. Nurses' skills and views will be measured using specific scales before the training and one month after the intervention to evaluate the training's effectiveness
- This study is expected to provide valuable insights into how AI can support clinical decision-making and help healthcare providers adapt to new technologies
- The research has been approved by the Yalova University Ethics Committee (Protocol 2026/183) and will be conducted between May and December 2026
Přehled studie
Postavení
Podmínky
Detailní popis
This randomized controlled, quasi-experimental study is designed to evaluate the impact of an applied artificial intelligence (AI)-supported nursing process training program on nurses' professional competence and their attitudes toward AI technology. The primary objective is to determine how the integration of AI tools into clinical decision-making affects nursing process efficiency and perception among healthcare professionals
. Methodology and Randomization: The study population consists of 414 nurses working at Yalova Education and Research Hospital
- Based on power analysis (power=0.95, alpha=0.05), a total of 78 nurses will be recruited and randomized into two groups: an intervention group (n=39) and a control group (n=39)
- Randomization will be conducted following the collection of baseline (pre-test) data
Intervention Protocol:
Phase 1 (Common Foundation): Both the intervention and control groups will receive a "Theoretical Training on the Nursing Process" to ensure baseline knowledge standardization . Phase 2 (AI Training - Intervention Group only): The intervention group will receive "AI-Supported Nursing Process Theoretical Training," which includes technical guidance on using AI tools (such as ChatGPT and Deepseek) for clinical care
,
. Phase 3 (Practical Application - Intervention Group only): Participants will engage in hands-on workshops using structured clinical cases. They will apply AI tools to generate care plans based on NANDA-I, NIC, and NOC taxonomies
- This phase includes structured debriefing and feedback sessions led by the researcher
The control group will only receive the standard theoretical nursing process education and will not have access to the AI training modules until the study is completed .
Data Collection and Assessment: Data will be collected using three instruments:
The Nurse Information Form (demographics and AI usage habits) . The Nursing Process Competence Scale (to measure clinical workflow skills)
. The Artificial Intelligence Perception and Attitude Scale (YAZAT-24) (to measure attitudes toward AI integration)
,
. Measurements will be conducted at two time points: baseline (pre-test) and one month following the intervention (post-test) to assess long-term retention and impact
,
. Statistical Analysis: Data analysis will be performed using SPSS 22.0. Normality will be assessed via the Kolmogorov-Smirnov test. Analysis will include descriptive statistics, independent samples t-test or Mann-Whitney U for group comparisons, and Repeated Measures ANOVA or Friedman tests for within-group changes over time
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Seher Gul Yavas, RN
- Telefonní číslo: +90 541 685 8806
- E-mail: seher.daglii@gmail.com
Studijní záloha kontaktů
- Jméno: Seyda can, Assoc. Prof. Dr.
- Telefonní číslo: +90 536 685 0312
- E-mail: seyda.cann@hotmail.com
Studijní místa
-
-
Yalova
-
Yalova, Yalova, Turecko (Türkiye)
- Yalova Training and Research Hospital
-
Kontakt:
- Seher Gul Yavas, RN
- Telefonní číslo: +90 541 685 8806
- E-mail: seher.daglii@gmail.com
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Volunteering to participate in the study.
- Working actively as a nurse in the specified institution (Yalova Training and Research Hospital).
- Not having previously used artificial intelligence in the nursing process.
Exclusion Criteria:
- Refusing to participate in the study.
- Having previously used artificial intelligence in the nursing process. Submitting incomplete data collection forms.
- Requesting to withdraw from the study.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Intervention Group
Participants will receive a standard theoretical education session on the nursing process.
Following this, they will receive an applied artificial intelligence-supported nursing process training and engage in case study practices using AI tools.
|
Participants will receive theoretical education on the artificial intelligence-supported nursing process and engage in applied case studies using AI tools in small groups.
Participants will receive a standard theoretical education session on the nursing process.
|
|
Aktivní komparátor: Control Group
Participants will receive only the standard theoretical education session on the nursing process.
They will not receive the artificial intelligence-supported training or case study practices during the study period.
|
Participants will receive a standard theoretical education session on the nursing process.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Nursing Process Competence
Časové okno: Baseline (pre-test) and 1 month after the intervention (post-test)
|
This outcome is measured using the Nursing Process Competence Scale.
The scale consists of 24 items and 5 sub-dimensions evaluated on a 5-point Likert scale.
The average score ranges from 1 to 5, and higher scores indicate higher nursing process competence
|
Baseline (pre-test) and 1 month after the intervention (post-test)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Artificial Intelligence Perception and Attitude
Časové okno: Baseline (pre-test) and 1 month after the intervention (post-test).
|
This outcome is measured using the Artificial Intelligence Perception and Attitude Scale (YAZAT-24).
The scale consists of 24 items and 4 sub-dimensions evaluated on a 7-point Likert scale.
Higher total scores indicate more positive perceptions and attitudes towards artificial intelligence.
|
Baseline (pre-test) and 1 month after the intervention (post-test).
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 2026/183
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .